Ocubio
(305) 204-0370

The therapy that
completes the picture.

Ocubio's Qualified Autologous Serum Eye Drops bring a new level of standardization, convenience, and adherence to ocular surface health. Prescribed by you, delivered to your patients.

Clinically standardizedFDA-registered laboratory processingNo prior auth. No admin burden.
Ocubio QASED benefits diagram: Neural Regeneration, Personalization, Restoration, Patient Adherence, Inflammation Control, Convenience

Trusted by ophthalmologists, cornea specialists, and optometrists nationwide.

Ocubio has really helped me think about autologous serum as a first line therapy for ocular surface disease patients.
Nandini Venkateswaran, MD Cataract Cornea Refractive Surgeon
Boston, MA

Schedule a call with one of our reps at your convenience.

Talk to a real person about onboarding, dosing, and patient logistics.

How it works

01

You Prescribe

Write the prescription through Ocubio's platform. No prior authorizations, no paperwork for your team.

02

Patient Chooses Their Cadence

Your patient logs in and selects a subscription schedule: monthly, quarterly, or semiannual.

03

The Kit Arrives, the Draw Is Easy

Patients receive a collection kit and schedule a blood draw at any Quest Diagnostics location nationwide. They can also opt for at-home mobile phlebotomy.

04

Treatment Delivered to Their Door

Processed QASED is shipped directly to the patient's home, room-temperature stable and ready to use.

Formulated for the full spectrum of ocular surface need.

Foundation
20%

Mild-to-moderate dry eye, maintenance.

Advanced
50%

Moderate-to-severe ocular surface disease.

All formulations are physician-directed. Dosage and concentration selected at prescriber discretion.

Become a provider

Register your practice.

Tell us where to reach you and a member of our team will be in touch shortly.

All fields required.
For Healthcare Providers

Everything you need to know about prescribing QASED.

QASED (Qualified Autologous Serum Eye Drops) is a personalized biologic derived from the patient's own blood serum. Unlike conventional autologous serum, Ocubio's QASED is highly standardized under rigorous quality protocols in FDA-registered laboratories, ensuring full confidence for both patients and providers.

QASED is a biologic compounded under physician direction, not an FDA-approved drug. It is used alongside other prescribed therapies for ocular surface health. Standard FDA disclaimer applies. No pre-approval from your medical team is required to prescribe.

QASED supports healthy ocular surface function in patients with conditions such as severe dry eye disease, Sjögren's syndrome, graft-versus-host disease (GVHD), neurotrophic keratitis, and post-refractive surgery complications, particularly where conventional therapies have been insufficient.

20% and 50% give providers enough range to treat most cases.

Ready to offer your patients the right support?

Join the growing network of providers prescribing Ocubio.